应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TLX Telix Pharmaceuticals Ltd. (Uplisting)
休市中 08-30 16:00:00 EDT
0.0000
+0.0000
--
最高
0.0000
最低
0.0000
成交量
0.00
今开
0.0000
昨收
0.0000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
3.51亿
成交额
0.00
换手率
0.00%
流通股本
1,700万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
澳洲放射性药物生物技术公司Telix Pharmaceuticals(TLX.US)拟IPO定价11.87美元 筹资2.02亿美元
智通财经 · 06-06
澳洲放射性药物生物技术公司Telix Pharmaceuticals(TLX.US)拟IPO定价11.87美元 筹资2.02亿美元
【澳洲放射性药物生物技术公司Telix Pharmaceuticals(TLX.US)拟IPO定价11.87美元 筹资2.
智通财经 · 06-06
【澳洲放射性药物生物技术公司Telix Pharmaceuticals(TLX.US)拟IPO定价11.87美元 筹资2.
加载更多
公司概况
公司名称:
Telix Pharmaceuticals Ltd. (Uplisting)
所属市场:
NASDAQ
上市日期:
--
主营业务:
Telix Pharmaceuticals Limited于2017年1月3日根据澳大利亚法律成立。该公司是一家商业阶段的生物制药公司,专注于治疗和诊断放射性药物的开发和商业化。他们的使命是通过将治疗和诊断模式相结合以造福患者,成为放射性药物的全球领导者,这是一种创新的精准医学概念,通常被称为“治疗学”。他们拥有广泛的候选治疗放射性药物产品,重点关注泌尿肿瘤学(前列腺和肾脏)、神经肿瘤学(神经胶质瘤)、肌肉骨骼肿瘤学(肉瘤)和骨髓调理。他们的治疗方法旨在将成像和治疗结合起来,“观察和治疗”癌症和罕见病,更好地为患者提供治疗决策和个性化治疗。
发行价格:
--
{"stockData":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":0,"timestamp":1725048000000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":17000000,"shares":351130000,"eps":0,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"08-30 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1725350400000},"adr":0,"listingDate":1718337600000,"adjPreClose":0,"volumeRatio":0},"requestUrl":"/m/hq/s/TLX","defaultTab":"news","newsList":[{"id":"2441723769","title":"澳洲放射性药物生物技术公司Telix Pharmaceuticals(TLX.US)拟IPO定价11.87美元 筹资2.02亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441723769","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441723769?lang=zh_cn&edition=full","pubTime":"2024-06-06 15:23","pubTimestamp":1717658633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,Telix Pharmaceuticals周三宣布了首次公开募股条款。这家总部位于澳大利亚北墨尔本的公司计划以每股11.87美元的价格发行1700万股美国存托股,筹资2.02亿美元。按照拟议价格计算,Telix Pharmaceuticals完全摊薄后的市值将达到42亿美元。Telix Pharmaceuticals成立于2017年,截至2024年3月31日的12个月营收为3.83亿美元。预计该公司将在2024年6月10日当周内定价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1131936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TLX"],"gpt_icon":0},{"id":"2441697847","title":"【澳洲放射性药物生物技术公司Telix Pharmaceuticals(TLX.US)拟IPO定价11.87美元 筹资2.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441697847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441697847?lang=zh_cn&edition=full","pubTime":"2024-06-06 15:23","pubTimestamp":1717658633,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPO","TLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telixpharma.com","compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0689},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2516},{"period":"ytd","weight":0.1859}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Telix Pharmaceuticals Limited于2017年1月3日根据澳大利亚法律成立。该公司是一家商业阶段的生物制药公司,专注于治疗和诊断放射性药物的开发和商业化。他们的使命是通过将治疗和诊断模式相结合以造福患者,成为放射性药物的全球领导者,这是一种创新的精准医学概念,通常被称为“治疗学”。他们拥有广泛的候选治疗放射性药物产品,重点关注泌尿肿瘤学(前列腺和肾脏)、神经肿瘤学(神经胶质瘤)、肌肉骨骼肿瘤学(肉瘤)和骨髓调理。他们的治疗方法旨在将成像和治疗结合起来,“观察和治疗”癌症和罕见病,更好地为患者提供治疗决策和个性化治疗。","exchange":"NASDAQ","name":"Telix Pharmaceuticals Ltd. (Uplisting)","nameEN":"Telix Pharmaceuticals Ltd. (Uplisting)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Telix Pharmaceuticals Ltd. (Uplisting)(TLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Telix Pharmaceuticals Ltd. (Uplisting)(TLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Telix Pharmaceuticals Ltd. (Uplisting),TLX,Telix Pharmaceuticals Ltd. (Uplisting)股票,Telix Pharmaceuticals Ltd. (Uplisting)股票老虎,Telix Pharmaceuticals Ltd. (Uplisting)股票老虎国际,Telix Pharmaceuticals Ltd. (Uplisting)行情,Telix Pharmaceuticals Ltd. (Uplisting)股票行情,Telix Pharmaceuticals Ltd. (Uplisting)股价,Telix Pharmaceuticals Ltd. (Uplisting)股市,Telix Pharmaceuticals Ltd. (Uplisting)股票价格,Telix Pharmaceuticals Ltd. (Uplisting)股票交易,Telix Pharmaceuticals Ltd. (Uplisting)股票购买,Telix Pharmaceuticals Ltd. (Uplisting)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Telix Pharmaceuticals Ltd. (Uplisting)(TLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Telix Pharmaceuticals Ltd. (Uplisting)(TLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}